Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
gp350
Description:
An Epstein–Barr virus envelope glycoprotein involved in viral attachment to host cells and targeted by antibodies and vaccines.
Primary topic:
Viral-associated cancers and disorders (66%)
Related topics:
Viral-associated cancers and disorders (66%),
CAR-T cell therapy research (8%)
OpenAlex ID:
keywords/gp350
Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d
1987
·
G R Nemerow
, C Mold
, et al.
·
Journal of Virology
·
416
PDF
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
2015
·
Masaru Kanekiyo
, Wei Bu
, et al.
·
Cell
·
384
PDF
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
2006
·
C. D. Shannon-Lowe
, B. Neuhierl
, et al.
·
Proceedings of the National Academy of Sciences
·
257
Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
1980
·
D A Thorley-Lawson
, K Geilinger
·
Proceedings of the National Academy of Sciences
·
224
An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein–Barr Virus Activation
2012
·
Feng-Hua Xu
, Dan Xiong
, et al.
·
JNCI Journal of the National Cancer Institute
·
214
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
2021
·
Xinle Cui
, Clifford M. Snapper
·
Frontiers in Immunology
·
199
PDF
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults
2007
·
Michel Moutschen
, Philippe Léonard
, et al.
·
Vaccine
·
189
Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication
2006
·
Jing Yuan
, Ellen Cahir-McFarland
, et al.
·
Journal of Virology
·
172
Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo
1982
·
D A Thorley-Lawson
, C A Poodry
·
Journal of Virology
·
155
PDF
Vaccine Development for Epstein-Barr Virus
2018
·
Jeffrey I. Cohen
·
Advances in experimental medicine and biology
·
153
Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene
1985
·
C Beisel
, J Tanner
, et al.
·
Journal of Virology
·
135
Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6
1993
·
L Flamand
, I Stefanescu
, et al.
·
Journal of Virology
·
127
PDF
Structure of the Epstein-Barr virus major envelope glycoprotein
2006
·
Gerda Szakonyi
, Michael G Klein
, et al.
·
Nature Structural & Molecular Biology
·
123
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice
2022
·
Chih-Jen Wei
, Wei Bu
, et al.
·
Science Translational Medicine
·
109
PDF
Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay
2009
·
Junji Sashihara
, Peter D. Burbelo
, et al.
·
Virology
·
100
Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA
2017
·
Samantha Correia
, Anne Palser
, et al.
·
Journal of Virology
·
95
PDF
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
2022
·
Ling Zhong
, Claude Krummenacher
, et al.
·
npj Vaccines
·
94
PDF
Roles of Epstein–Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells
2001
·
Seiji Maruo
, Lixin Yang
, et al.
·
Journal of General Virology
·
94
Progress in EBV Vaccines
2019
·
Dwain G. van Zyl
, Josef Mautner
, et al.
·
Frontiers in Oncology
·
90
PDF
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease
2020
·
Constanze Slabik
, Maja Kalbarczyk
, et al.
·
Molecular Therapy — Oncolytics
·
88
PDF
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
2016
·
Xinle Cui
, Zhouhong Cao
, et al.
·
Vaccine
·
87
Expression and secretion in yeast of a 400-kda envelope glycoprotein derived from epstein-barr virus
1987
·
Loren D. Schultz
, Jerry Tanner
, et al.
·
Gene
·
82
EBV Structural Antigens, gp350 and gp85, as Targets for Ex Vivo Virus-Specific CTL During Acute Infectious Mononucleosis: Potential Use of gp350/gp85 CTL Epitopes for Vaccine Design
1999
·
Rajiv Khanna
, Martina Sherritt
, et al.
·
The Journal of Immunology
·
79
PDF
EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL
2011
·
Romana Ruiss
, Simon Jochum
, et al.
·
PLoS ONE
·
76
PDF
Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell Death
2001
·
Gareth J. Inman
, Ulrich K. Binné
, et al.
·
Journal of Virology
·
74
Show more works
View as search
Works count:
213
Citation count:
6,322
Year
Topic
Type